Campbell & Co Investment Adviser’s Graco GGG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,087
Closed -$1.11M 1155
2026
Q1
$1.11M Sell
13,087
-22,915
-64% -$2.03M 0.06% 476
2025
Q4
$2.95M Buy
36,002
+4,127
+13% +$340K 0.14% 219
2025
Q3
$2.71M Buy
31,875
+12,834
+67% +$1.1M 0.2% 116
2025
Q2
$1.64M Buy
+19,041
New +$1.58M 0.1% 303
2024
Q3
Sell
-60,017
Closed -$4.76M 1183
2024
Q2
$4.76M Buy
60,017
+36,209
+152% +$3.03M 0.4% 29
2024
Q1
$2.23M Buy
23,808
+20,525
+625% +$1.82M 0.19% 119
2023
Q4
$285K Sell
3,283
-6,755
-67% -$531K 0.03% 935
2023
Q3
$732K Buy
+10,038
New +$793K 0.09% 375
2023
Q1
Sell
-22,360
Closed -$1.5M 894
2022
Q4
$1.5M Buy
22,360
+18,190
+436% +$1.21M 0.36% 28
2022
Q3
$250K Buy
+4,170
New +$268K 0.06% 543
2021
Q2
Sell
-4,113
Closed -$295K 585
2021
Q1
$295K Buy
+4,113
New +$292K 0.18% 235
2019
Q4
Sell
-24,452
Closed -$1.13M 716
2019
Q3
$1.13M Buy
+24,452
New +$1.16M 0.42% 19
2015
Q2
Sell
-107,565
Closed -$2.59M 185
2015
Q1
$2.59M Buy
+107,565
New +$2.68M 1.63% 5

Other funds holding GGG

Campbell & Co Investment Adviser's GGG Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Graco (GGG) in Q2 2026, closing a stake of 13,087 shares — an estimated $1.11M sold.

Campbell & Co Investment Adviser first reported a position in GGG in Q1 2015 and held it in 13 quarters. The position peaked at $4.76M in Q2 2024. 731 funds tracked by Wall St. Rank hold GGG as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Graco position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 13,087 Graco shares in Q2 2026, an estimated $1.11M.
  • Campbell & Co Investment Adviser first reported a position in Graco in Q1 2015 and held it in 13 quarters.
  • Campbell & Co Investment Adviser's Graco position peaked at $4.76M in Q2 2024.
  • 731 funds tracked by Wall St. Rank held Graco as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.